OTTMUSG00000004968 Inhibitors
Chemical inhibitors of Krtap2-4-like focus on compounds that indirectly influence this protein by targeting signaling pathways crucial for keratinocyte differentiation and proliferation. The underlying principle is to disrupt the pathways that regulate keratin expression and function, thereby affecting the activity of Krtap2-4-like, which is integral to hair follicle structure and function. Erlotinib, Gefitinib, and Lapatinib are EGFR inhibitors that, by modulating the EGFR signaling, indirectly impact Krtap2-4-like. Inhibition of EGFR affects downstream signaling pathways related to keratinocyte differentiation, a process in which Krtap2-4-like plays a significant role. Sorafenib, a RAF kinase inhibitor, and Dasatinib, targeting SRC-family kinases, also follow a similar approach. By disrupting the MAPK/ERK and SRC pathways respectively, they influence the functional activity of Krtap2-4-like in hair follicle development.
Imatinib and Nilotinib, with their selective inhibition of BCR-ABL tyrosine kinase, and Bosutinib, an SRC/ABL kinase inhibitor, target pathways that are critical for cell growth and differentiation. This affects Krtap2-4-like's role in hair follicle morphology and keratinization. Similarly, multi-targeted inhibitors like Sunitinib, Pazopanib, and Vandetanib, by acting on VEGFR, PDGFR, and other kinases, modulate pathways that are influential in keratinocyte behavior and keratin expression. Finally, Crizotinib, an inhibitor of ALK and ROS1, contributes to the regulation of cell growth and differentiation, thereby indirectly influencing Krtap2-4-like's activity in hair follicle development and function. These inhibitors showcase the strategy of targeting upstream signaling molecules and pathways to indirectly inhibit the functional role of Krtap2-4-like in hair structure and development.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
Erlotinib is an EGFR inhibitor that can indirectly inhibit Krtap2-4-like by targeting the EGFR signaling pathway. EGFR, being upstream in the signaling cascade, modulates keratin expression and function. By inhibiting EGFR, erlotinib can reduce the functional activity of Krtap2-4-like, involved in hair follicle development and keratinocyte differentiation. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib, a RAF kinase inhibitor, indirectly inhibits Krtap2-4-like by disrupting the MAPK/ERK pathway, which is crucial for cell differentiation and proliferation. By inhibiting RAF kinases, sorafenib interferes with downstream signaling that affects keratinocyte growth and differentiation, thereby influencing Krtap2-4-like function. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib, another EGFR inhibitor, can indirectly inhibit Krtap2-4-like. It acts on the EGFR pathway, which influences keratinocyte differentiation and keratin expression. Through the inhibition of EGFR, gefitinib can diminish the functional activity of Krtap2-4-like, affecting hair follicle morphology and function. | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $420.00 | 32 | |
Lapatinib, a dual inhibitor of EGFR and HER2, can indirectly inhibit Krtap2-4-like. By targeting EGFR and HER2, lapatinib impacts the pathways influencing keratinocyte behavior and keratin expression. This action can lead to a reduction in Krtap2-4-like activity, which is pivotal in hair follicle structure and function. | ||||||
Vandetanib | 443913-73-3 | sc-220364 sc-220364A | 5 mg 50 mg | $167.00 $1353.00 | ||
Vandetanib, an inhibitor of VEGFR, EGFR, and RET tyrosine kinases, can indirectly inhibit Krtap2-4-like by affecting multiple signaling pathways involved in keratinocyte differentiation and keratin expression. Through its multi-target action, vandetanib can influence the functional role of Krtap2-4-like in hair structure. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib, a SRC-family kinase inhibitor, can indirectly inhibit Krtap2-4-like. It acts on the SRC pathway, which is involved in the regulation of keratinocyte behavior and keratin expression. Through inhibiting SRC kinases, dasatinib can impact Krtap2-4-like activity in hair follicle development and function. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib, a BCR-ABL tyrosine kinase inhibitor, can indirectly inhibit Krtap2-4-like by influencing the cellular signaling pathways related to keratinocyte growth and differentiation. Through its action on BCR-ABL, imatinib can modulate the functional role of Krtap2-4-like in hair follicle structure and keratinization. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
Sunitinib, a multi-targeted receptor tyrosine kinase inhibitor, can indirectly inhibit Krtap2-4-like by impacting pathways involved in keratinocyte differentiation and proliferation. It targets receptors like VEGFR and PDGFR, thereby influencing the downstream effects on Krtap2-4-like function in hair follicle development. | ||||||
Pazopanib | 444731-52-6 | sc-396318 sc-396318A | 25 mg 50 mg | $130.00 $182.00 | 2 | |
Pazopanib, a multi-target tyrosine kinase inhibitor, can indirectly inhibit Krtap2-4-like by affecting various signaling pathways crucial for keratinocyte behavior and keratin expression. Through its action on kinases like VEGFR, PDGFR, and c-KIT, pazopanib influences Krtap2-4-like functionality in hair follicle structure. | ||||||
Nilotinib | 641571-10-0 | sc-202245 sc-202245A | 10 mg 25 mg | $209.00 $413.00 | 9 | |
Nilotinib, a selective BCR-ABL inhibitor, can indirectly inhibit Krtap2-4-like by targeting signaling pathways involved in cell differentiation and proliferation. Its action on BCR-ABL modulates downstream effects on keratinocyte behavior, influencing Krtap2-4-like function in hair and skin structure. | ||||||